Anti-Human CD195 (CCR5) [Clone HEK/1/85a/7a] – Purified in vivo GOLD™ Functional Grade
Anti-Human CD195 (CCR5) [Clone HEK/1/85a/7a] – Purified in vivo GOLD™ Functional Grade
Product No.: I-2501
Clone HEK/1/85a/7a Target CD195 Formats AvailableView All Product Type Monoclonal Antibody Alternate Names C-C chemokine receptor type 5, CC-CKR-5, CCR-5, CHEMR13, HIV-1 fusion coreceptor Isotype Rat IgG2b κ Applications FC , ICC |
Antibody DetailsProduct DetailsReactive Species Human Host Species Rat Recommended Isotype Controls Recommended Dilution Buffer Immunogen CHO cells transfected with full-length human CD195 (CCR5). Product Concentration ≥ 5.0 mg/ml Endotoxin Level < 1.0 EU/mg as determined by the LAL method Purity ≥95% monomer by analytical SEC ⋅ >95% by SDS Page Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. Product Preparation Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day 2-8°C RRIDAB_2893835 Applications and Recommended Usage? Quality Tested by Leinco FC The suggested concentration for this CD195 antibody for staining cells in flow cytometry is ≤ 1.0 μg per 106 cells in a volume of 100 μl. Titration of the reagent is recommended for optimal performance for each application.
Additional Applications Reported In Literature ? ICC Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Clone HEK/1/85a/7a recognizes an epitope on human CCR5.
Background CCR5 antibody, HEK/1/85a/7a, recognizes C-C chemokine receptor type 5 (CCR5), also known as CD195, CC-CKR-5, CHEMR13, and HIV-1 fusion coreceptor. CCR5 is a 45 kDa seven-transmembrane G-protein-coupled receptor (GPCR). CCR5 is expressed on a subset of memory T cells, macrophages, and immature dendritic cells (DCs) and is upregulated by proinflammatory cytokines1,2. CCR5 binds to inflammatory CC-chemokines, including CCL3 (macrophage inflammatory protein (MIP)-1α), CCL4 (MIP-1β), and RANTES, which increases intracellular calcium levels and results in cytoskeletal rearrangement and chemotactic cell migration3. CCR5 is also the coreceptor for HIV-1 following binding of viral gp120 to CD44-7. The levels of CCR5 on cells influence the rate of entry of HIV-1, and patients with lower levels of CCR5 exhibit immunity against infection8. CCR5 also contributes to other human diseases, including type I diabetes9 and cancer10.
Antigen Distribution CCR5 is expressed on memory T cells, macrophages, and immature dendritic cells (DCs).
NCBI Gene Bank ID Leinco Antibody AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. The clone HEK/1/85a/7a is specifically designed and used for in vivo mouse studies as a functional grade antibody targeting human CD195 (CCR5). This antibody is manufactured with special considerations for in vivo applications that distinguish it from standard research antibodies. In Vivo Functional Grade SpecificationsThe HEK/1/85a/7a clone is available as an "in vivo GOLD Functional Grade" antibody, which indicates it has been specifically purified and tested for use in live animal studies. This functional grade designation ensures the antibody meets the stringent requirements necessary for in vivo applications, including appropriate purity levels and reduced endotoxin content. Low Endotoxin ManufacturingFor in vivo mouse studies, this antibody is manufactured with low endotoxin levels (less than 1.0 EU/mg), which is crucial for preventing inflammatory responses that could confound experimental results. Some manufacturers also offer ultra-low endotoxin versions with even lower endotoxin content (<0.5 EU/mg) at higher purity levels (98% versus 95%) for more sensitive in vivo applications. Species Reactivity ConsiderationsAn important limitation for in vivo mouse studies is that the HEK/1/85a/7a antibody shows species-specific reactivity. The antibody recognizes human CCR5 but has limited cross-reactivity with mouse CCR5. This means that for standard mouse studies, researchers would typically need to use humanized mouse models that express human CCR5 rather than the native mouse protein, or the antibody would be used in xenograft models where human cells are transplanted into immunocompromised mice. Dosing and AdministrationThe antibody is available in bulk quantities suitable for in vivo studies, including 5mg, 25mg, 50mg, and 100mg sizes, with multi-gram quantities available upon request. The specific dosing would depend on the experimental design, mouse strain, and study objectives, though exact protocols would need to be optimized for each specific research application. The rat IgG2b isotype of this antibody is well-suited for in vivo applications as it typically has good stability and appropriate pharmacokinetic properties for mouse studies. Storage Temperature for Clone HEK/1/85a/7aFor the sterile packaged (bulk/lyophilized, unopened) clone HEK/1/85a/7a (anti-human CD195/CCR5 antibody):
Additional Details
Summary Table
Always refer to the manufacturers datasheet for the specific product lot, as storage recommendations may vary slightly depending on formulation and packaging. The antibody HEK/1/85a/7a is an anti-CCR5 antibody widely used for detecting the chemokine receptor CCR5 in research, especially in studies involving receptor pharmacology or immunology. In the literature, it is often used alongside other antibodies and proteins in experiments involving cell lines expressing or lacking CCR5 or related chemokine receptors. Commonly used antibodies or proteins with HEK/1/85a/7a:
Additional context:
Researchers may choose further antibodies based on the experimental context (e.g., anti-MICA for immunology, various anti-GPCR/ligand antibodies for receptor pharmacology). However, for studies specifically referencing HEK/1/85a/7a, anti-CCR5, anti-CD4, and anti-G protein antibodies are the most directly and frequently mentioned counterparts in the literature. Key Findings from Citations of Clone HEK/1/85a/7aClone Identification and Applications
Role in Scientific Research
Summary Table: Key Points
ConclusionThe HEK/1/85a/7a clone is a well-established tool for detecting human CCR5, with confirmed equivalence to HEK/1/85a. It is widely used in immunology and virology research, particularly for studying HIV infection and immune cell phenotypes, but there is no evidence in the available citations that it is directly associated with a specific scientific breakthrough or novel biological insight. Its value lies in its reliability for CCR5 detection in experimental systems. References & Citations1. Mackay CR., et al. (1997) Proc Natl Acad Sci. 94(5):1925-30 2. Doms RW., et al. (1999) Proc Natl Acad Sci. 96(9):5215-5220 3. Parmentier M., et al. (1996) Biochemistry. 35(11):3362-7 4. Berger EA., et al. (1996) Science. 272(5270):1955-8 5. Sodroski J., et al. (1996) Cell. 1996 85(7):1135-48 6. Doms RW., et al. (1996) Cell. 85(7):1149-58 7. Paxton WA., et al. (1996) Nature. 381(6584):667-73 8. Sheppard HW., et al. (1997) Nat Med. 3(10):1160-2 9. Delovitch TL., et al. (2000) J Immunol. 165(2):1102-10 10. Casagrande N., et al. (2020) Cancers (Basel). 12(7):1765 Technical ProtocolsCertificate of Analysis |
Formats Available
